ZYTOPROTEC
Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major disease areas. The Company was founded by a team of professionals that combine extensive experience in business administration, clinical research, pharmaceutical product development, as well as company and patent law.
ZYTOPROTEC
Social Links:
Industry:
Biopharma Biotechnology Medical
Founded:
2007-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.zytoprotec.com
Total Employee:
11+
Status:
Active
Contact:
43 1 406 20 02
Email Addresses:
[email protected]
Total Funding:
2 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon SSL By Default HSTS Nginx Microsoft Exchange Online Office 365 Mail
Similar Organizations
4D pharma Research Ltd
4D pharma Research Limited, a biotechnology company, develops drug compounds from gut bacteria for the prevention.
DorsaVI
DorsaVi is a biotechnology company developing innovative motion analysis device technologies.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Intercytex Group
Intercytex Group is a biotechnology company developing cell-based therapies for the repair and regeneration of skin and hair.
Luciole Medical
Luciole Medical is a Swiss medical technology company developing brain oxygenation monitoring systems.
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
NeuroGeneration
Neurogeneration is a biotechnology company that develops new treatments and products for patients.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Baxter International
Baxter International investment in Series A - Zytoprotec
Official Site Inspections
http://www.zytoprotec.com
- Host name: pl009.a1webhosting.at
- IP address: 193.81.82.82
- Location: Austria
- Latitude: 48.2
- Longitude: 16.3667
- Timezone: Europe/Vienna
More informations about "Zytoprotec"
Zytoprotec - Crunchbase Company Profile & Funding
Zytoprotec is an Austrian biotechnology company, founded in 2007 to apply ground-breaking findings in the area of cytoprotection to the development of new treatment options for major …See details»
ZYTOPROTEC AT A GLANCE
Zytoprotec started this journey in the field of peritoneal dialysis (PD), one of two forms of dialysis, the other being hemodialysis (HD). Dialysis is a necessary, live-saving procedure for patients …See details»
Zytoprotec Company Profile 2024: Valuation, Funding & Investors
Zytoprotec has 10 total employees. What industry is Zytoprotec in? Zytoprotec’s primary industry is Drug Discovery. Is Zytoprotec a private or public company? Zytoprotec is a Private …See details»
Zytoprotec GmbH - Life Sciences Directory
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna ... Zytoprotec, a biomedical company founded in 2007, has consistently moved its lead product – PDprotec® – …See details»
Zytoprotec - Overview, News & Similar companies | ZoomInfo.com
Zytoprotec is a clinical stage life sciences company based in Vienna, Austria. The Company's lead product, PD-protec®, is a patent-protected soluti on for peritoneal dialysis. PD-protec® …See details»
Zytoprotec Company Profile - Office Locations, Competitors ... - Craft
Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach. It offers PD-protec, a patent-protected solution for peritoneal dialysis (PD). In …See details»
Zytoprotec - Funding, Financials, Valuation & Investors - Crunchbase
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How …See details»
Zytoprotec - Contacts, Employees, Board Members, Advisors
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas.See details»
Zytoprotec - Products, Competitors, Financials, Employees, …
The designation will provide Zytoprotec with several development incentives, including market exclusivity for up to 7 years upon FDA approval, the company said in a press release. …See details»
Zytoprotec GMBH / zytoprotec.com
Das Zytoprotec Team freut sich, dass dies trotz des seit rund 2 Jahren schwierigen Finanzierungsumfeld für Startups gelungen ist. Und wir bedanken uns bei allen neuen …See details»
Zytoprotec GmbH - Wien, Austria - bionity.com
May 25, 2012 Zytoprotec is a private biotechnology company developing drugs based on active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in …See details»
Zytoprotec - VentureRadar
Zytoprotec is a clinical stage biotechnology company developing drugs exploiting active cytoprotection as a novel therapeutic approach. Research by Zytoprotec has shown that in …See details»
Zytoprotec - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Zytoprotec is an Austrian biotechnology company developing new treatment options for major disease areas.See details»
Zytoprotec's Novel Dialysis Product Meets Both Endpoints in …
Jun 13, 2017 Prof. Dr. Uwe Schlokat, Chairman of the Zytoprotec Board, stated: "Over the next decade the number of patients suffering from chronic kidney failure is expected to grow to …See details»
Key Milestones - zytoprotec.com
Zytoprotec opens first Christian-Doppler-Laboratory (a public-private-partnership) aimed at biomarker research in the field of peritoneal dialysis: 06/2014. Start of double-blinded, placebo …See details»
NEWS & ARCHIVE - zytoprotec.com
The Zytoprotec team is delighted that this was possible despite the difficult financing environment for start-ups during the last two years. And we would like to thank all new investors for the trust …See details»
Prospective, randomized, multi-center, double-blind, controlled, …
Sponsors Zytoprotec Most Recent Events 09 Jun 2017 Results from this trial published in a Zytoprotec Media Release. 17 Feb 2017 Status changed from active, no longer recruiting to …See details»
Pipeline / zytoprotec.com
Zytoprotec has the ability to screen a broad range of pharmacologically active substances (compounds) for their potential therapeutic benefit in terms of stimulating cells’ own or inherent …See details»
Science & Technology / zytoprotec.com
Zytoprotec’s science and unique therapeutic approach. During evolution, cells of all species have developed and optimized a powerful mechanism to protect against stress. ... S.G. Zarogiannis, …See details»